Latest Insider Transactions at Mersana Therapeutics, Inc. (MRSN)
This section provides a real-time view of insider transactions for Mersana Therapeutics, Inc. (MRSN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Mersana Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Mersana Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 28
2024
|
Mohan Bala SVP, Chief Development Officer |
SELL
Open market or private sale
|
Direct |
1,884
-3.33%
|
$1,884
$1.9 P/Share
|
|
Oct 25
2024
|
Mohan Bala SVP, Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,250
+9.94%
|
-
|
|
Oct 03
2024
|
Timothy B Lowinger SVP, Chief Sci.&Tech. Officer |
SELL
Open market or private sale
|
Direct |
5,598
-2.32%
|
$5,598
$1.96 P/Share
|
|
Oct 03
2024
|
Ashish Mandelia VP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
3,361
-6.58%
|
$3,361
$1.96 P/Share
|
|
Oct 03
2024
|
Mohan Bala SVP, Chief Development Officer |
SELL
Open market or private sale
|
Direct |
5,598
-10.0%
|
$5,598
$1.96 P/Share
|
|
Oct 03
2024
|
Alejandra Carvajal SVP, Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
5,598
-8.08%
|
$5,598
$1.96 P/Share
|
|
Oct 03
2024
|
Brian De Schuytner SVP, COO & CFO |
SELL
Open market or private sale
|
Direct |
5,598
-5.57%
|
$5,598
$1.96 P/Share
|
|
Oct 02
2024
|
Timothy B Lowinger SVP, Chief Sci.&Tech. Officer |
SELL
Open market or private sale
|
Direct |
8,089
-3.24%
|
$16,178
$2.0 P/Share
|
|
Oct 02
2024
|
Ashish Mandelia VP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
4,855
-8.67%
|
$9,710
$2.0 P/Share
|
|
Oct 02
2024
|
Mohan Bala SVP, Chief Development Officer |
SELL
Open market or private sale
|
Direct |
8,089
-12.63%
|
$16,178
$2.0 P/Share
|
|
Oct 02
2024
|
Alejandra Carvajal SVP, Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
8,089
-10.45%
|
$16,178
$2.0 P/Share
|
|
Oct 02
2024
|
Brian De Schuytner SVP, COO & CFO |
SELL
Open market or private sale
|
Direct |
8,089
-7.45%
|
$16,178
$2.0 P/Share
|
|
Oct 01
2024
|
Timothy B Lowinger SVP, Chief Sci.&Tech. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+16.7%
|
-
|
|
Oct 01
2024
|
Ashish Mandelia VP, Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+34.89%
|
-
|
|
Oct 01
2024
|
Mohan Bala SVP, Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+43.84%
|
-
|
|
Oct 01
2024
|
Alejandra Carvajal SVP, Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+39.25%
|
-
|
|
Oct 01
2024
|
Brian De Schuytner SVP, COO & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+31.54%
|
-
|
|
Sep 12
2024
|
Martin H. Huber Jr. President, CEO |
SELL
Open market or private sale
|
Direct |
50,423
-30.24%
|
$50,423
$1.76 P/Share
|
|
Sep 11
2024
|
Martin H. Huber Jr. President, CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
166,750
+50.0%
|
-
|
|
Jan 16
2024
|
Timothy B Lowinger SVP, Chief Sci.&Tech. Officer |
SELL
Open market or private sale
|
Direct |
10,409
-4.96%
|
$20,818
$2.71 P/Share
|
|
Jan 16
2024
|
Ashish Mandelia VP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
5,025
-17.72%
|
$10,050
$2.71 P/Share
|
|
Jan 16
2024
|
Tushar Misra SVP, Chief Manuf. Officer |
SELL
Open market or private sale
|
Direct |
3,357
-15.74%
|
$6,714
$2.71 P/Share
|
|
Jan 16
2024
|
Anna Protopapas Director |
SELL
Open market or private sale
|
Direct |
29,399
-19.02%
|
$58,798
$2.71 P/Share
|
|
Jan 16
2024
|
Mohan Bala SVP, Chief Development Officer |
SELL
Open market or private sale
|
Direct |
3,431
-19.62%
|
$6,862
$2.71 P/Share
|
|
Jan 16
2024
|
Brian De Schuytner SVP, COO & CFO |
SELL
Open market or private sale
|
Direct |
9,327
-14.61%
|
$18,654
$2.71 P/Share
|
|
Jan 16
2024
|
Alejandra Carvajal SVP, Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
4,381
-13.78%
|
$8,762
$2.71 P/Share
|
|
Jan 15
2024
|
Timothy B Lowinger SVP, Chief Sci.&Tech. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,208
+3.56%
|
-
|
|
Jan 15
2024
|
Ashish Mandelia VP, Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,352
+8.48%
|
-
|
|
Jan 15
2024
|
Anna Protopapas Director |
BUY
Exercise of conversion of derivative security
|
Direct |
38,958
+11.86%
|
-
|
|
Jan 15
2024
|
Brian De Schuytner SVP, COO & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,208
+7.64%
|
-
|
|
Jan 14
2024
|
Timothy B Lowinger SVP, Chief Sci.&Tech. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,792
+2.4%
|
-
|
|
Jan 14
2024
|
Ashish Mandelia VP, Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,783
+17.21%
|
-
|
|
Jan 14
2024
|
Tushar Misra SVP, Chief Manuf. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,458
+6.4%
|
-
|
|
Jan 14
2024
|
Anna Protopapas Director |
BUY
Exercise of conversion of derivative security
|
Direct |
16,750
+12.66%
|
-
|
|
Jan 14
2024
|
Brian De Schuytner SVP, COO & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,250
+10.1%
|
-
|
|
Jan 14
2024
|
Alejandra Carvajal SVP, Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+7.29%
|
-
|
|
Jan 13
2024
|
Timothy B Lowinger SVP, Chief Sci.&Tech. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,375
+4.71%
|
-
|
|
Jan 13
2024
|
Ashish Mandelia VP, Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,645
+12.68%
|
-
|
|
Jan 13
2024
|
Tushar Misra SVP, Chief Manuf. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,083
+26.28%
|
-
|
|
Jan 13
2024
|
Anna Protopapas Director |
BUY
Exercise of conversion of derivative security
|
Direct |
31,250
+24.02%
|
-
|
|
Jan 13
2024
|
Mohan Bala SVP, Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,750
+33.35%
|
-
|
|
Jan 13
2024
|
Brian De Schuytner SVP, COO & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+17.43%
|
-
|
|
Jan 13
2024
|
Alejandra Carvajal SVP, Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,958
+23.42%
|
-
|
|
Jan 02
2024
|
David M Mott Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,810
+1.47%
|
-
|
|
Jan 02
2024
|
Willard H Dere Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,112
+13.49%
|
-
|
|
Oct 26
2023
|
Mohan Bala SVP, Chief Development Officer |
SELL
Open market or private sale
|
Direct |
1,912
-17.96%
|
$1,912
$1.13 P/Share
|
|
Oct 25
2023
|
Mohan Bala SVP, Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,250
+36.99%
|
-
|
|
Oct 02
2023
|
Willard H Dere Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,011
+24.98%
|
-
|
|
Oct 02
2023
|
David M Mott Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,873
+2.66%
|
-
|
|
Sep 11
2023
|
Anna Protopapas Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,643
+19.76%
|
-
|